Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Division of Pathology, Fukui Saiseikai Hospital, Fukui, Japan.
Histopathology. 2021 Jan;78(2):310-320. doi: 10.1111/his.14222. Epub 2020 Sep 15.
BACKGROUND/AIMS: Precursor lesions of small duct type intrahepatic cholangiocarcinoma (small duct iCCA) have not been clarified so far. We hypothesised that precursor lesions may be frequently distributed in the background liver of small duct iCCA.
We determined by histology the presence of bile duct adenomas and von Meyenburg complexes as candidate precursor lesions in the background liver of small duct iCCA, with other primary liver carcinomas as control. Subjects included 28 patients with small duct iCCA, 29 with large duct iCCAs, 60 with combined hepatocellular-cholangiocarcinoma (Comb) and 40 with hepatocellular carcinoma (HCC). The prevalence of bile duct adenomas in the background liver was significantly higher in small duct iCCA (35.7%) compared to other primary liver carcinomas (Comb, 4.9%; 10%, HCC) (P < 0.01). The prevalence of bile duct adenomas was significantly associated with the presence of von Meyenburg complexes and ductal plate malformation-like patterns in small duct iCCAs and Combs. Von Meyenburg complexes were detected in 11 small duct iCCA (39.3%), five large duct iCCAs (17.2%), 10 Comb (16.4%) and 13 HCC (33.3%), respectively (P > 0.05). Small duct iCCAs showed altered expression of ARID1A (46.4%), p53 (39.3%), PBRM1 (14.3%), IMP3 (85.7%) and EZH2 (82.1%), whereas these markers were negative in bile duct adenomas.
Bile duct adenomas may be precursor lesions of small duct iCCAs. Alteration of ARID1A, p53 or PBRM1 may be involved in the carcinogenesis of small duct iCCAs.
背景/目的:小胆管型肝内胆管癌(小胆管 iCCA)的癌前病变尚未阐明。我们假设癌前病变可能在小胆管 iCCA 的背景肝中频繁分布。
我们通过组织学确定了胆管腺瘤和迈耶伯格复合体作为小胆管 iCCA 背景肝中候选癌前病变的存在,以其他原发性肝癌为对照。研究对象包括 28 例小胆管 iCCA 患者、29 例大胆管 iCCA 患者、60 例肝细胞癌-胆管细胞癌(Comb)患者和 40 例肝细胞癌(HCC)患者。小胆管 iCCA 背景肝中胆管腺瘤的患病率明显高于其他原发性肝癌(Comb,4.9%;10%,HCC)(P<0.01)。胆管腺瘤的患病率与小胆管 iCCA 和 Comb 中迈耶伯格复合体和导管板畸形样模式的存在显著相关。11 例小胆管 iCCA(39.3%)、5 例大胆管 iCCA(17.2%)、10 例 Comb(16.4%)和 13 例 HCC(33.3%)分别检测到迈耶伯格复合体(P>0.05)。小胆管 iCCA 显示 ARID1A(46.4%)、p53(39.3%)、PBRM1(14.3%)、IMP3(85.7%)和 EZH2(82.1%)的表达改变,而胆管腺瘤则呈阴性。
胆管腺瘤可能是小胆管 iCCA 的癌前病变。ARID1A、p53 或 PBRM1 的改变可能参与小胆管 iCCA 的癌变。